Skip to main content

Myocardial Infarct

0
Pipeline Programs
3
Companies
9
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Zoll
ZollCA - San Jose
1 program
Supersaturated oxygenN/A1 trial
Active Trials
NCT06662890Recruiting56Est. Nov 2038
Revalesio
RevalesioWA - Tacoma
1 program
RNS60PHASE_11 trial
Active Trials
NCT01264783Completed12Est. Sep 2011
Bristol Myers Squibb
1 program
InsulinPHASE_45 trials
Active Trials
NCT00831779Completed116Est. Aug 2010
NCT01411930Completed15Est. Aug 2011
NCT00699790Completed58Est. Dec 2009
+2 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Bristol Myers SquibbInsulin
Bristol Myers SquibbInsulin
Bristol Myers SquibbInsulin
Bristol Myers SquibbInsulin
Bristol Myers SquibbInsulin
Bristol Myers SquibbInsulin
RevalesioRNS60
Bristol Myers SquibbInsulin
ZollSupersaturated oxygen

Clinical Trials (9)

Total enrollment: 1,598 patients across 9 trials

NCT01411930Bristol Myers SquibbInsulin

Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics

Start: Mar 2009Est. completion: Aug 201115 patients
Phase 4Completed
NCT00237471Bristol Myers SquibbInsulin

Impact of Tight Glycaemic Control in Acute Myocardial Infarction

Start: Oct 2005Est. completion: May 200640 patients
Phase 4Terminated
NCT00347087Bristol Myers SquibbInsulin

Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure

Start: Jul 2004Est. completion: Jun 200736 patients
Phase 4Completed
NCT00673231Bristol Myers SquibbInsulin

Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin

Start: Apr 2008Est. completion: Jan 20111,240 patients
Phase 3Completed
NCT00831779Bristol Myers SquibbInsulin

Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes

Start: Apr 2009Est. completion: Aug 2010116 patients
Phase 2Completed
NCT00699790Bristol Myers SquibbInsulin

Proof of Confidence Study of CCR2 Antagonist (BMS-741672) in Insulin Resistance

Start: Feb 2009Est. completion: Dec 200958 patients
Phase 2Completed
NCT01264783RevalesioRNS60

Safety and Tolerability of RNS60 Given by IV to Healthy Subjects

Start: Jul 2011Est. completion: Sep 201112 patients
Phase 1Completed
NCT00135434Bristol Myers SquibbInsulin

Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism

Start: Sep 2004Est. completion: Jun 200525 patients
Phase 1Completed
NCT06662890ZollSupersaturated oxygen

Heart Attack Blood Oxygen Therapy Trial

Start: Oct 2024Est. completion: Nov 203856 patients
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 1,598 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.